Valuation: Abpro Bio Co., Ltd.

Capitalization 128B 88.23M 81.1M 78.06M 68.31M 127M 7.67B 140M 895M 339M 3.24B 331M 324M 13.08B P/E ratio 2022
-13.9x
P/E ratio 2023 -5.89x
Enterprise value 120B 82.67M 75.99M 73.14M 64M 119M 7.19B 131M 838M 318M 3.03B 310M 304M 12.26B EV / Sales 2022
4.73x
EV / Sales 2023 5.8x
Free-Float
92.81%
Yield 2022 *
-
Yield 2023 -
More valuation ratios * Estimated data
Dynamic Chart
Abpro Bio Co., Ltd. announced that it has received KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. 24-06-16 CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. 24-06-12 CI
Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 23-05-15 CI
Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim. 22-12-15 CI
Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion. 22-09-25 CI
Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding 21-12-23 CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding 21-10-13 CI
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm 21-06-17 CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm 21-06-15 CI
KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro Bio Co., Ltd. for KRW 2.8 billion. 20-12-21 CI
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd., Abpro Bio Co., Ltd. 20-12-14 CI
Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd. 20-11-25 CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd. and other investors 20-11-17 CI
More news
1 day-0.67%
1 week-9.20%
Current month-12.17%
1 month-20.00%
3 months-43.19%
6 months-34.66%
Current year-34.22%
More quotes
1 week
290
Extreme 290
296
1 month
290
Extreme 290
296
Current year
290
Extreme 290
296
1 year
290
Extreme 290
296
3 years
290
Extreme 290
296
5 years
290
Extreme 290
296
10 years
290
Extreme 290
296
More quotes
Manager TitleAgeSince
Chief Executive Officer 63 2024-04-29
Sales & Marketing 55 2014-10-31
Director TitleAgeSince
Director/Board Member 63 2019-08-22
Director/Board Member 57 2020-04-08
Director/Board Member 55 2024-04-29
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.67%-9.20%-48.43%-63.05% 58.04M
+3.36%+4.16%-17.81%+115.00% 3.12B
+2.36%+3.48%+66.58% - 2.62B
+0.81%-0.40%+87.55%-17.30% 2.29B
-2.33%+8.15%+3.14%+59.16% 2.16B
+0.98%+6.96%+36.80%-9.04% 2.03B
-0.26%-2.74%+90.88%+203.23% 1.85B
+2.57%+1.31%+21.95%+44.91% 1.72B
+0.91%-1.68%-19.17%+19.98% 1.68B
+1.71%-4.73%-10.74%-30.08% 1.65B
Average +0.94%-0.90%+21.07%+35.87% 1.92B
Weighted average by Cap. +1.24%-0.37%+28.86%+52.09%
See all sector performances

Financials

2022 2023
Net sales 22.11B 15.23M 14M 13.47M 11.79M 21.92M 1.32B 24.11M 154M 58.54M 558M 57.09M 55.93M 2.26B 25.38B 17.48M 16.06M 15.46M 13.53M 25.16M 1.52B 27.67M 177M 67.18M 641M 65.51M 64.19M 2.59B
Net income -8.14B -5.61M -5.16M -4.96M -4.34M -8.07M -488M -8.88M -56.89M -21.56M -206M -21.03M -20.6M -832M -25.74B -17.73M -16.3M -15.69M -13.73M -25.52M -1.54B -28.07M -180M -68.16M -650M -66.46M -65.11M -2.63B
Net Debt -10.89B -7.5M -6.9M -6.64M -5.81M -10.8M -652M -11.88M -76.09M -28.84M -275M -28.12M -27.55M -1.11B -8.07B -5.56M -5.11M -4.92M -4.31M -8M -484M -8.81M -56.4M -21.38M -204M -20.85M -20.42M -825M
More financial data * Estimated data
Logo Abpro Bio Co., Ltd.
Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also engages in original equipment manufacturing business (OEM). The Company operates its business within domestic markets and foreign markets such as China and Europe countries.
Employees
51
More about the company
Date Price Change Volume
25-03-14 296.00 -0.67% 585,794
25-03-13 298.00 +2.76% 2,192,732
25-03-12 290.00 -5.54% 1,192,001
25-03-11 307.00 +0.66% 540,516
25-03-10 305.00 -6.44% 1,819,777

End-of-day quote Korea S.E., March 13, 2025

More quotes
  1. Stock Market
  2. Equities
  3. A195990 Stock